What anticoagulant and antiplatelet therapy is recommended after a diagnostic coronary angiography without stent placement?

Anticoagulant and Antiplatelet Therapy After Diagnostic PCI

After diagnostic coronary angiography without stent placement, aspirin 75-100 mg daily is recommended lifelong if the patient has evidence of significant obstructive coronary artery disease on imaging 1.

For Patients WITHOUT Indication for Oral Anticoagulation

If Obstructive CAD is Documented

• Start aspirin 75-100 mg daily and continue indefinitely 1
• This applies even without prior MI or revascularization, as long as definitive evidence of significant obstructive CAD was found during the angiography
• If aspirin intolerant: Use clopidogrel 75 mg daily as an alternative 1

Special Considerations

• No dual antiplatelet therapy (DAPT) is needed after diagnostic angiography alone—DAPT is only indicated after stent placement 1
• Clopidogrel may be preferred over aspirin in patients with concurrent peripheral arterial disease or history of ischemic stroke/TIA 1

For Patients WITH Indication for Oral Anticoagulation (e.g., Atrial Fibrillation)

After Diagnostic Angiography Without Stenting

• Continue oral anticoagulation (OAC) monotherapy alone 1, 2
• NOACs are preferred over warfarin when initiating anticoagulation 1
• Adding aspirin to OAC may be considered only in patients with history of MI AND high risk of recurrent ischemic events who do NOT have high bleeding risk 1

Evidence Supporting OAC Monotherapy

Recent meta-analysis data from 2025 demonstrates that OAC monotherapy in patients with AF and stable CAD showed no increased ischemic risk compared to OAC plus antiplatelet therapy, but significantly reduced major bleeding (HR 0.59) 2. This supports the guideline recommendation to avoid routine addition of antiplatelet therapy after diagnostic procedures in anticoagulated patients.

Periprocedural Management

If Patient Already on Anticoagulation

• Diagnostic angiography can be safely performed without interrupting anticoagulation 3, 4, 5
• Uninterrupted anticoagulation actually reduces access site bleeding complications compared to interrupted therapy with bridging 4, 5
• Radial access is preferred and safe with therapeutic anticoagulation 3, 5

Critical Caveat

• Avoid supratherapeutic anticoagulation (INR >3) as this increases access site complications significantly 5
• If INR >3, consider delaying elective diagnostic procedures until therapeutic range achieved

Common Pitfalls to Avoid

1. Do not prescribe DAPT after diagnostic angiography alone—this is only for post-stenting patients
2. Do not routinely add aspirin to anticoagulation in AF patients without high-risk features for recurrent ischemia
3. Do not interrupt anticoagulation for diagnostic procedures—this increases bleeding risk paradoxically
4. Do not use bridging therapy for diagnostic angiography—associated with higher bleeding rates including need for transfusion 5

The key distinction is that diagnostic angiography without intervention requires only single antiplatelet therapy (or OAC alone if indicated), whereas stent placement triggers the need for DAPT protocols outlined in the guidelines 1.